Jiang Wu

Title: Jiang Wu: Innovator in Pharmaceutical Research

Introduction

Jiang Wu is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds for medical applications. With a total of two patents to his name, his work focuses on addressing critical health issues such as diabetes.

Latest Patents

Jiang Wu's latest patents include a phenyl C-glucoside derivative containing a deoxyglucose structure. This invention provides a preparation method and various uses, particularly in the formulation of medicaments for treating diabetes. The patent outlines a method for synthesizing this derivative, emphasizing its simplicity and cost-effectiveness, making it suitable for large-scale industrial production. Additionally, the invention includes a cocrystal of (1S)-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1,6-dideoxy-D-glucose and L-proline, along with its preparation method and applications.

Career Highlights

Jiang Wu is affiliated with the Tianjin Institute of Pharmaceutical Research, where he conducts his research and development activities. His work has been instrumental in advancing pharmaceutical sciences, particularly in creating effective treatments for diabetes.

Collaborations

Jiang Wu collaborates with esteemed colleagues such as Guilong Zhao and Yuli Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jiang Wu's contributions to pharmaceutical research highlight his commitment to developing effective treatments for diabetes. His innovative patents reflect his expertise and dedication to improving healthcare outcomes.